Kilitch Drugs India Ltd has announced the resignation of Venkita Subramanian Rajan, a Non-Executive Independent Director, effective October 21, 2026. Rajan has cited pre-occupation and other personal commitments as the reason for stepping down, and will also cease to chair or be a member of the Audit Committee, Nomination and Remuneration Committee, and Stakeholder Relationship Committee of the board.
In a letter submitted to the board, Rajan stated there are no other material reasons for his resignation beyond those mentioned. The company has acknowledged the development and will reflect the change across its governance framework. The departure marks a notable moment for Kilitch Drugs as it reassesses board composition and committee oversight amid ongoing business considerations.
As Kilitch Drugs moves to maintain strong independent oversight, the board is expected to evaluate next steps to sustain balance and governance standards. The company will continue to pursue its growth agenda while ensuring robust governance through any forthcoming changes to its board and committees.